Table 1.
|
BI-RADS classification |
Isolated DCIS |
IDC-DCIS |
Isolated-IDC |
Isolated ILC |
Other tumours |
Total |
---|---|---|---|---|---|---|---|
Diagnostic imaging | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
Sonography |
0 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
|
1 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
|
2 |
0 (0%) |
0 (0%) |
0 (%) |
0 (0%) |
1 (11.1%) |
1 (0.8%) |
|
3 |
0 (0%) |
0 (0%) |
3 (7.3%) |
0 (0%) |
0 (0%) |
3 (2.5%) |
|
4 |
10 (66.7%) |
17 (44.8%) |
10 (24.4%) |
8 (44.4%) |
5 (55.6%) |
50 (41.3%) |
|
5 |
5 (33.3%) |
20 (52.6%) |
28 (68.3%) |
10 (55.6%) |
3 (33.3%) |
66 (54.5%) |
|
6 |
0 (0%) |
1 (2.6%) |
0 (0%) |
0 (0%) |
0 (0%) |
1 (0.8%) |
Mammography |
0 |
0 (0%) |
1 (2.6%) |
0 (0%) |
1 (5.6%) |
0 (0%) |
2 (1.7%) |
|
1 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
|
2 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
|
3 |
1 (6.7%) |
4 (10.5%) |
3 (7.3%) |
0 (0%) |
1 (11.1%) |
9 (7.4%) |
|
4 |
1 (6.7%) |
12 (31.6%) |
17 (41.5%) |
11 (61.1%) |
5 (55.6%) |
46 (38.0%) |
|
5 |
13 (86.6%) |
19 (50%) |
17 (41.5) |
6 (33.3%) |
3 (33.3%) |
58 (47.9%) |
|
6 |
0 (0%) |
2 (5.3%) |
4 (9.7%) |
0 (0%) |
0 (0%) |
6 (5.0%) |
MRI |
0 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
|
1 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
|
2 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
|
3 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (%) |
0 (0%) |
0 (0%) |
|
4 |
0 (0%) |
2 (5.3%) |
4 (9.8%) |
0 (0%) |
0 (0%) |
7 (5.8%) |
|
5 |
9 (60%) |
22 (57.9%) |
26 (63.4%) |
8 (44.4%) |
3 (33.3%) |
68 (56.2%) |
6 | 6 (40%) | 14 (36.8%) | 11 (26.8%) | 9 (50%) | 6 (66.7%) | 46 (38.0%) |
DCIS Ductal carcinoma in situ, IDC Invasive ductal carcinoma, ILC Invasive lobular carcinoma.